BioCentriq™

A Cell & Gene Therapy Development and Manufacturing Center of Excellence 


Get in Touch


About BioCentriq


BioCentriq is a full service CDMO. We offer product development and clinical production for cell and gene therapies.  BioCentriq was founded in 2019 and launched our pilot development plant at the same time. In October of 2020 we completed the validation of our GMP center and opened the doors for clinical manufacturing. 

Our mission is to accelerate the advancement of cell and gene therapies by improving the efficiency and effectiveness of manufacturing processes and technologies. To support that mission, we also offer custom and standard workforce development programs to help close the skills gap that exists in the industry today.


Learn More

 

Want to learn more?


Request our full capabilities brochure!


 

Dr. Joanne Beck
Dr. Joanne BeckChief Operating Officer, Boston Pharmaceuticals
NJII has made significant progress in the area of regenerative medicine and we are very excited about their new center and the opportunity for companies of varying sizes to leverage the center for cell and gene therapy development and manufacturing projects as well as workforce development.
Jose Lozano, CEO
Jose Lozano, CEOPresident & CEO, ChooseNJ
“This is a complete game-changer for New Jersey. BioCentriq is a state-of-the-art facility that will attract cutting-edge companies and innovation from around the world.”
Peter Marks, Center For Biologics Evaluation and Research (CBER)
Peter Marks, Center For Biologics Evaluation and Research (CBER)U.S. Food and Drug Administration (FDA)
“Right now, the throughput for cell and gene therapies is limited. We don’t fully understand how to manufacture therapies in a reproducible manner, from scaling up and scaling out. This type of facility will hopefully get us to the place where that will be possible.”

 

Get In Touch


Please use the form below to get in touch with a member of our team.

  • This field is for validation purposes and should be left unchanged.